Patient and Drug Management: What Every Doctor in Hong Kong Should Know

Authors: Rendy Ng (Link to bio) and Dr. Alan Wong (Link to bio)

‍

Patient and medication management are not just clinical responsibilities — they are among the most litigated and disciplined areas in Hong Kong's medical profession. A review of Medical Council of Hong Kong (MCHK) disciplinary inquiries shows that many cases do not arise from rare or complex errors, but from routine systems failures in documentation, prescribing, and follow-up.

This article distils recurring fact patterns from disciplinary decisions and translates them into practical safeguards for doctors and clinic operators.

What are the Key Risk Areas for Patient Management?

Disciplinary cases frequently involve not a single catastrophic mistake, but a series of small lapses that collectively fall below acceptable standards.

Common fact patterns include:

• Failure to justify clinical decisions: Doctors are criticised for ordering investigations or procedures without documenting clinical reasoning. In several MCHK cases, even where treatment itself was not inherently inappropriate, the absence of recorded justification led to findings of misconduct.

• Diagnostic delay with inadequate safety-netting: A recurring issue is failure to act on evolving symptoms. Patients presenting with non-specific complaints (e.g. persistent pain, neurological symptoms) were not followed up adequately, nor given clear instructions on when to return. The Council has emphasised that "watchful waiting" must be supported by documented contingency advice.

• Inadequate follow-up systems: Clinics relying on patients to self-initiate follow-up, especially after abnormal test results, have been criticised. In some cases, results were reviewed but not communicated, leading to delayed diagnosis and disciplinary findings.

• Consent treated as a formality: Consent disputes often arise where risks, alternatives, or uncertainties were not clearly explained. The Council tends to place significant weight on documentation — if it is not recorded, it is often treated as not having been done.

What are the High-Risk Regulatory Breaches in Drug Management?

Medication-related misconduct is one of the most consistently prosecuted areas, particularly where regulatory obligations are clear and objective.

Typical violations seen in MCHK cases include:

• Dangerous Drugs Ordinance (DDO) non-compliance - This is a strict liability risk area. Common breaches include:
  
  • Failure to maintain a proper dangerous drugs register
  • Entries not made contemporaneously
  • Missing or inconsistent stock balances
  • Lack of clear authorisation controls over access

Even absent patient harm, these failures alone have resulted in disciplinary sanctions.

• Prescribing without proper clinical basis: There are repeated cases involving prescription of sedatives, opioids, or antibiotics without adequate clinical assessment or documentation. Over-prescription, particularly in aesthetic or general practice settings, attracts scrutiny.

• Allergy and contraindication failures: Doctors have been disciplined for prescribing medications despite documented allergies, or for failing to check/update allergy records. The Council expects this to be a systematic, not ad hoc, safeguard.

• Labelling and dispensing errors: Incorrect or incomplete labelling, especially missing dosage instructions or patient identifiers, has been cited as falling below professional standards. In clinic settings where doctors both prescribe and dispense, the risk is heightened.

What the Medical Council of Hong Kong Looks For in Drug, Patient and Clinic Management?

Across decisions, several themes emerge in how the Council assesses liability:

• Systems over individual excuses: "I was busy" or "staff oversight" is not a defence. The Council expects doctors to maintain systems that prevent foreseeable errors.

• Documentation as primary evidence: In disciplinary proceedings, contemporaneous notes carry decisive weight. Reconstructed records are viewed with caution unless supported by objective evidence.

• Pattern of practice: Even if a single incident appears minor, evidence of repeated lapses (e.g. poor record-keeping across multiple patients) significantly increases the likelihood of a misconduct finding.

How can Clinics in Hong Kong better Control Risks?

Based on disciplinary trends, effective clinics implement structured controls rather than relying on individual diligence:

• Clinical documentation protocols: Standardise note-taking to include: presenting complaint, differential diagnosis, justification for investigations/treatment, and follow-up plan.

• Closed-loop follow-up systems: Ensure abnormal results trigger mandatory patient notification and documented follow-up actions. Avoid passive reliance on patients returning.

• Dangerous drugs governance: Maintain:
  
  • A bound or secure register with real-time entries
  • Regular stock reconciliation
  • Restricted access with clear accountability

• Allergy and medication safety checks: Embed mandatory allergy verification in every prescribing workflow, ideally supported by electronic prompts or checklists.

• Separation of roles (where feasible): Introduce internal checks between prescribing and dispensing functions to reduce error risk, even within smaller clinics.

• Audit and training: Periodic internal audits, especially on drug registers and patient records, are viewed favourably in both prevention and mitigation.

Strategic Takeaways for Medical Practitioners

• Most disciplinary cases are preventable through basic system discipline rather than advanced medical knowledge

• Documentation is not administrative — it is your primary legal defence

• Drug management breaches are often "technical" but carry serious consequences

• Early legal input can materially affect both outcome and exposure

‍

Disclaimer: Nothing herein shall be interpreted as legal advice to any person. Readers are encouraged to consult their legal representatives for independent advice. The information provided is based on overall observations and the experience of the practitioners of the firm at the time of writing. The content may change without prior notification depending on changes in the law. If there are two versions of the article in different languages, the English version will prevail in case of discrepancies.

About Us:

Rendy Ng Law Firm is a law firm based in Hong Kong, providing a full range of commercial legal services for all sectors, with particular focus on supporting professionals and businesses in the medical and veterinary, consumer goods and retail and entertainment industries to achieve sustainable success. By combining legal guidance with understanding of business practicalities, we ensure that our clients receive support tailored to their business goals and individual needs. Please feel free to reach out to our team should you have any questions about our services.

For enquiries, please contact us at:

P | +(852) 6033-3072 E | info@rknlegal.com W | www.rknlegal.com